Quantum Dot Composition Curing Uniformity via Segmented Cross-linking

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing quantum dot compositions face challenges in achieving an optimal curing degree and uniformity in forming quantum dot layers, leading to inefficiencies in light-emitting devices due to suboptimal cross-linking agents and solvents.

Innovation Solution

A quantum dot composition incorporating a cross-linking agent with four or more moieties represented by Formula A, combined with a mixed solvent system comprising cyclohexylbenzene, hexadecane, and octylbenzene, promotes improved curing and uniformity by adjusting solubility parameters and boiling points, enhancing the formation of a quantum dot layer with improved characteristics.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If a conventional cross-linking agent is used, then the composition is simple, but the curing degree and uniformity are insufficient

Engineering Contradiction:
Improvecuring degree uniformityVSAvoidcross-linking agent structure
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The cross-linking agent is divided into multiple functional moieties (Formula A with four or more groups) that can independently cross-link with quantum dot surface ligands. This segmentation allows each moiety to contribute to curing at different locations, achieving uniform curing degree throughout the quantum dot layer while maintaining a manageable molecular structure.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention uses a composite cross-linking agent structure combining multiple cross-linkable groups (Formula A) with a central connector (Formula 1 or 2). This composite approach integrates different cross-linking functionalities into a single molecule, achieving both high curing degree and structural feasibility without excessive complexity.

Inventive Principle:
Principle #40Composite materials

2Manufacturing precision

If a single solvent is used, then the composition is simple, but the curing degree and layer uniformity are insufficient

Engineering Contradiction:
Improvelayer uniformityVSAvoidsolvent system composition
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The solvent system is segmented into three distinct solvents with different properties: first solvent (cyclohexylbenzene) for quantum dot dissolution, second solvent (hexadecane) with higher boiling point for controlled evaporation, and third solvent (octylbenzene) for cross-linking agent solubility. Each solvent performs a specific function, and their combined action achieves uniform quantum dot layer formation and curing.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The mixed solvent system performs multiple functions simultaneously: dissolving quantum dots, dissolving cross-linking agent, controlling evaporation rate, and facilitating uniform film formation. This multi-functional solvent system achieves superior layer uniformity and curing degree while managing the added complexity through functional specialization.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Reliability

If conventional solvents are used, then the composition is simple, but agglomeration occurs and photoluminescence efficiency decreases

Engineering Contradiction:
Improvephotoluminescence efficiencyVSAvoidsolvent system
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The solvent system parameters are optimized by selecting specific compounds with defined boiling points and surface tensions. The second solvent has a higher boiling point than the first, creating a controlled evaporation sequence that prevents rapid drying and agglomeration. The third solvent's specific structure (Formula 3) provides appropriate solubility parameters to maintain quantum dot dispersion while enabling cross-linking.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The mixed solvent system acts as an intermediary between the quantum dot precursors and the final cured layer. It provides a controlled environment for uniform distribution, prevents premature aggregation, and enables gradual curing. The solvent mixture mediates the transition from dissolved precursors to uniform quantum dot layer, maintaining photoluminescence efficiency throughout the process.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The proposed composition results in a quantum dot layer with enhanced curing degree and uniformity, reducing agglomeration rates and maintaining high photoluminescence efficiency, thereby improving the performance and reliability of light-emitting devices.

Implementation Method 1

a cross-linking agent having four or more moieties each independently represented by Formula A

Methodology Applied
Scientific EffectCross-linking: Chemical Bonding

Implementation Method 2

quantum dots... excellent color purity and high luminescence efficiency

Methodology Applied
Scientific EffectPhotoluminescence: Photoluminescence

Data Source

PatentUS20240318073A1Quantum dot composition and light-emitting device prepared using the same
Publication Date: 2024.09.26 SAMSUNG DISPLAY CO LTD
  • US20240318073A1 patent drawing
  • US20240318073A1 patent drawing
  • US20240318073A1 patent drawing

AI summary

Embodiments provide is a quantum dot composition that includes quantum dots, a cross-linking agent including four or more moieties represented by Formula A, and a mixed solvent including a first solvent, a second solvent, and a third solvent. The second solvent has a higher boiling point than the first solvent, the second solvent has a lower surface tension than the first solvent, and the third solvent includes a compound represented by Formula 3. Formula A and Formula 3 are explained in the specification:Ar2—R2.  [Formula 3]